Walker, Elizabeth Arquin https://orcid.org/0000-0002-6328-7673
Gonzalez, Jeffrey S
Tripputi, Mark T
Dagogo-Jack, Samuel https://orcid.org/0000-0001-5318-9677
Matulik, Margaret J
Montez, Maria G
Tadros, Sameh
Edelstein, Sharon L https://orcid.org/0000-0001-8457-4404
Clinical trials referenced in this document:
Documents that mention this clinical trial
The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures (Results)
https://doi.org/10.2337/dc20-1129
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
https://doi.org/10.1016/s0140-6736(09)61457-4
Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study
https://doi.org/10.1136/bmjdrc-2020-001537
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study
https://doi.org/10.1016/s0140-6736(12)60525-x
Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study
https://doi.org/10.1161/circulationaha.121.056756
Use of a Metabolic Syndrome Severity
<i>Z</i>
Score to Track Risk During Treatment of Prediabetes: An Analysis of the Diabetes Prevention Program
https://doi.org/10.2337/dc18-1079
Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study
https://doi.org/10.2337/dc16-2376
Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease (Results)
https://doi.org/10.2337/dc18-2254
Factors Affecting the Decline in Incidence of Diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS)
https://doi.org/10.2337/db14-0333
Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
https://doi.org/10.2337/dc21-1046
Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
https://doi.org/10.2337/dc18-1970
Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program
https://doi.org/10.1136/bmjdrc-2020-001953
Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS) (Results)
https://doi.org/10.2337/dc19-0244
Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program (Results)
https://doi.org/10.2337/db19-0236
Documents that mention this clinical trial
The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures (Results)
https://doi.org/10.2337/dc20-1129
Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study
https://doi.org/10.1136/bmjdrc-2020-001537
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study
https://doi.org/10.1016/s0140-6736(12)60525-x
Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study
https://doi.org/10.1161/circulationaha.121.056756
Use of a Metabolic Syndrome Severity
<i>Z</i>
Score to Track Risk During Treatment of Prediabetes: An Analysis of the Diabetes Prevention Program
https://doi.org/10.2337/dc18-1079
Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors (Results)
https://doi.org/10.2337/db19-0097
Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study
https://doi.org/10.2337/dc16-2376
Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease (Results)
https://doi.org/10.2337/dc18-2254
Factors Affecting the Decline in Incidence of Diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS)
https://doi.org/10.2337/db14-0333
Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
https://doi.org/10.2337/dc21-1046
Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
https://doi.org/10.2337/dc18-1970
Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program
https://doi.org/10.1136/bmjdrc-2020-001953
Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation (Results)
https://doi.org/10.2337/dc17-1116
Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS) (Results)
https://doi.org/10.2337/dc19-0244
Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program (Results)
https://doi.org/10.2337/db19-0236
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK111022, U01 DK048489)